These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 6138794)

  • 1. Pharmacological characterization of the receptors involved in the apomorphine-induced polyphasic modifications of locomotor activity in mice.
    Protais P; Bonnet JJ; Costentin J
    Psychopharmacology (Berl); 1983; 81(2):126-34. PubMed ID: 6138794
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Comparative study of the pharmacological properties of sultopride sulpiride and other antipsychotic drugs: influence of sultopride, sulpiride and other antipsychotic drugs on spontaneous locomotor activity and changes in locomotor activity induced by apomorphine and clonidine in mice].
    Horikomi K; Fujita M
    Yakubutsu Seishin Kodo; 1986 Sep; 6(3):339-52. PubMed ID: 2880435
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characteristics of the dopamine receptors involved in the anorectic effects of apomorphine in mice.
    Duterte-Boucher D; Naudin B; Costentin J
    Fundam Clin Pharmacol; 1989; 3(4):337-46. PubMed ID: 2553567
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Involvement of different dopamine receptors in rat diphasic motility response to apomorphine.
    Vaccheri A; Dall'Olio R; Gandolfi O; Montanaro N
    Psychopharmacology (Berl); 1986; 89(3):265-8. PubMed ID: 2873607
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effects of some atypical neuroleptics on apomorphine-induced behaviors as a measure of their relative potencies in blocking presynaptic versus postsynaptic dopamine receptors.
    Robertson A; MacDonald C
    Pharmacol Biochem Behav; 1986 Jun; 24(6):1639-43. PubMed ID: 2874567
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Implications of dopamine agonist-induced hypothermia following increased density of dopamine receptors in the mouse.
    Feigenbaum JJ; Yanai J
    Neuropharmacology; 1985 Aug; 24(8):735-41. PubMed ID: 3939327
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Psychopharmacological profile of amisulpride: an antipsychotic drug with presynaptic D2/D3 dopamine receptor antagonist activity and limbic selectivity.
    Perrault G; Depoortere R; Morel E; Sanger DJ; Scatton B
    J Pharmacol Exp Ther; 1997 Jan; 280(1):73-82. PubMed ID: 8996184
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dopamine agonist-induced locomotor activity in rats treated with 6-hydroxydopamine at differing ages: functional supersensitivity of D-1 dopamine receptors in neonatally lesioned rats.
    Breese GR; Napier TC; Mueller RA
    J Pharmacol Exp Ther; 1985 Aug; 234(2):447-55. PubMed ID: 3926987
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CCK-8 injected into the nucleus accumbens attenuates the supersensitive locomotor response to apomorphine in 6-OHDA and chronic-neuroleptic treated rats.
    Weiss F; Ettenberg A; Koob GF
    Psychopharmacology (Berl); 1989; 99(3):409-15. PubMed ID: 2574480
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacological characteristics of dopamine receptors involved in the dual effect of dopamine agonists on yawning behaviour in rats.
    Protais P; Dubuc I; Costentin J
    Eur J Pharmacol; 1983 Oct; 94(3-4):271-80. PubMed ID: 6140175
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The rise of body temperature induced by the stimulation of dopamine D1 receptors is increased in acutely reserpinized mice.
    Vasse M; Chagraoui A; Henry JP; Protais P
    Eur J Pharmacol; 1990 May; 181(1-2):23-33. PubMed ID: 1974857
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence that apomorphine and pergolide induce rotation in rats by different actions on D1 and D2 receptor sites.
    Herrera-Marschitz M; Ungerstedt U
    Eur J Pharmacol; 1984 Feb; 98(2):165-76. PubMed ID: 6143675
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antipsychotic substances and dopamine in the rat brain; behavioral studies reveal distinct dopamine receptor systems.
    Van Ree JM; Elands J; Király I; Wolterink G
    Eur J Pharmacol; 1989 Aug; 166(3):441-52. PubMed ID: 2572429
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antagonism of hypothermia and behavioral response to apomorphine: a simple, rapid and discriminating test for screening antidepressants and neuroleptics.
    Puech AJ; Chermat R; Poncelet M; Doaré L; Simon P
    Psychopharmacology (Berl); 1981; 75(1):84-91. PubMed ID: 6117921
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of chronic lithium on behavioral and biochemical indices of dopamine receptor supersensitivity in the rat.
    Pittman KJ; Jakubovic A; Fibiger HC
    Psychopharmacology (Berl); 1984; 82(4):371-7. PubMed ID: 6427831
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Time course of rat motility response to apomorphine: a simple model for studying preferential blockade of brain dopamine receptors mediating sedation.
    Montanaro N; Vaccheri A; Dall'Olio R; Gandolfi O
    Psychopharmacology (Berl); 1983; 81(3):214-9. PubMed ID: 6139839
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypokinesia in mice and catalepsy in rats elicited by morphine associated with antidopaminergic agents, including atypical neuroleptics.
    Barghon R; Protais P; Colboc O; Costentin J
    Neurosci Lett; 1981 Nov; 27(1):69-73. PubMed ID: 6120489
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Supersensitivity to apomorphine in experimentally induced hypokinesia and drug-induced modifications of the apomorphine response.
    Voith K
    Psychopharmacology (Berl); 1980; 70(3):247-54. PubMed ID: 6777797
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuroleptic inhibition of 6,7-ADTN-induced hyperactivity after injection into the nucleus accumbens. Specificity and comparison with other models.
    Arnt J
    Eur J Pharmacol; 1983 May; 90(1):47-55. PubMed ID: 6135618
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Atypical neuroleptics suppress dopaminergic behavioral supersensitivity.
    Schremmer C; Morgenstern R; Fink H; Ott T
    Psychopharmacology (Berl); 1990; 100(3):399-403. PubMed ID: 1969173
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.